MEDIROM Healthcare Technologies Inc. Announces September 2022 Key Performance Indicators (KPIs)

Total Customers Served: 71,770 – Sales Per Customer: JPY 6,505 – Customer Repeat Ratio: 80.8%

September 2022_Number of Salons

September 2022_Number of Salons

September 2022_Operation Ratio

September 2022_Operation Ratio

September 2022_Repeat Ratio

September 2022_Repeat Ratio

September 2022_Sales per Customer

September 2022_Sales per Customer

September 2022_Total Customers Served

September 2022_Total Customers Served

NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of September 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.

The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of September 2022.

  • The number of salons was 312 in September 2022, down from 316 in the year-ago period. From September 2021 to September 2022, 14 unprofitable salons were closed through scrap-and-build and 10 new salons were opened.
  • Total customers served increased to 71,770 in September 2022 from 65,130 in the year-ago period. The increase is primarily attributed to the increase in the number of salons with available financial and customer data and economic recovery from COVID-19 pandemic.
  • Sales per customer increased to JPY 6,505 in September 2022 from JPY 6,428 in September 2021. The increase is primarily attributed to the upselling of value-added optional services.
  • Repeat ratio, a measure of repeat customers, decreased slightly to 80.8% in September 2022 from 82.0% in the year-ago period.
  • Operation ratio increased to 50.3% in September 2022 from 46.7% in the year-ago period. The increase is primarily attributed to the adjustment of staffing according to salon scale.
  • The total number of salons with data increased to 233 in September 2022 from 221 in September 2021. The increase is attributed to the completion of the replacement of the customer management system in certain salons. The number of salons with data decreases when we close salons with data available and increases as we open salons with such data.
  Number of Salons (*1) Number of Salons with Data (*2) Total Customers Served (*3) Sales per Customer (*4) Repeat Ratio (*5) Operation Ratio (*6)
September-21 316 221 65,130 JPY 6,428 82.0 % 46.7 %
October-21 316 221 68,608 JPY 6,486 83.3 % 48.9 %
November-21 316 221 65,569 JPY 6,466 81.9 % 47.7 %
December-21 312 221 71,173 JPY 6,634 81.7 % 50.5 %
January-22 312 221 62,747 JPY 6,570 82.4 % 48.2 %
February-22 310 219 54,443 JPY 6,662 83.8 % 46.4 %
March-22 310 217 61,417 JPY 6,595 82.4 % 46.5 %
April-22 309 232 69,986 JPY 6,616 82.0 % 48.3 %
May-22 308 232 77,291 JPY 6,461 79.6 % 50.1 %
June-22 307 231 73,259 JPY 6,511 80.4 % 50.3 %
July-22 309 231 76,521 JPY 6,668 80.6 % 50.3 %
August-22 311 232 72,250 JPY 6,705 80.1 % 49.8 %
September-22 312 233 71,770 JPY 6,505 80.8 % 50.3 %

(*1) Number of Salons: Includes our directly-operated salons and franchisees’ salons.
(*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.
(*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.
(*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.
(*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.
(*6) Operation Ratio: The ratio of therapists’ in-service time to total therapists’ working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.

*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.

About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates 312 (as of September 30, 2022) relaxation salons across Japan, Re.Ra.Ku®, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en

Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Photo accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/d988500b-abd6-4b70-9ff2-f5aa5f462f6a

https://www.globenewswire.com/NewsRoom/AttachmentNg/d2beb7ce-54ec-4126-a2f6-85243b27072d

https://www.globenewswire.com/NewsRoom/AttachmentNg/79c109bf-3fef-4702-9a23-a9cc708b106d

https://www.globenewswire.com/NewsRoom/AttachmentNg/55c005fa-80ab-4a0f-848e-3df3b82d300c

https://www.globenewswire.com/NewsRoom/AttachmentNg/5ef22495-9c94-4f97-b0b8-a25e33d4af1a

CONTACT: Contacts
Investor Relations Team
ir@medirom.co.jp

Staff

Recent Posts

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

2 hours ago

Global High-Throughput Screening (HTS) Market to Reach USD 50.2 Billion by 2029: Opportunities, Challenges, and Growth Drivers | MarketsandMarkets™

CHICAGO, July 12, 2024 /PRNewswire/ -- The global high-throughput screening market is poised for substantial growth,…

2 hours ago

PPG Biosensors Market to be dominated by Smartwatches Segment to reach USD 1001.73 Mn by 2030- Says Stellar Market Research

PUNE, India, July 12, 2024 /PRNewswire/ -- Stellar Market Research, a leading Healthcare business research…

2 hours ago

ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells

SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised…

2 hours ago

Report: Medicare System Can Do More to Protect Beneficiaries

Alliance for Aging Research says utilization management practices such as step therapy and prior authorization…

2 hours ago